Cargando…
A review of recent advances in the diagnosis of cardiac amyloidosis, treatment of its cardiac complications, and disease-modifying therapies
Cardiac amyloidosis (CA), a significant condition resulting in infiltrative cardiomyopathy and heart failure with preserved ejection fraction (HFpEF), is caused by extracellular deposition of amyloid fibrils in the heart. Even though this has been known for an extended period, its prevalence in elde...
Autores principales: | Raval, Maharshi, Siddiq, Sajid, Sharma, Kamal, Sanghvi, Labdhi, Jain, Akhil, Patel, Sagar, Trivedi, Jaahnavee, Uttam Chandani, Kanishka, Patel, Dhriti, Desai, Rupak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995736/ https://www.ncbi.nlm.nih.gov/pubmed/36911240 http://dx.doi.org/10.12688/f1000research.130285.1 |
Ejemplares similares
-
Clinical challenges in the management of cardiac amyloidosis complicating aortic stenosis and coronary artery disease
por: Raval, Maharshi, et al.
Publicado: (2022) -
Left atrial appendage doppler velocity as a predictor of recurrence of atrial fibrillation after transesophageal echocardiogram guided electrical cardioversion
por: Raval, Maharshi, et al.
Publicado: (2023) -
Etiologies and Predictors of 30-Day Readmission in Heart Failure: An Updated Analysis
por: Jain, Akhil, et al.
Publicado: (2023) -
Untangling Amyloidosis: Recent Advances in Cardiac Amyloidosis
por: Kim, Darae, et al.
Publicado: (2020) -
Cardiac Amyloidosis Treatment
por: Stern, Lily K., et al.
Publicado: (2022)